Treatment of visceral fat obesity.
Fujioka
S
S
Second Department of Internal Medicine, Osaka University Medical School, Japan.
Matsuzawa
Y
Y
Tokunaga
K
K
Keno
Y
Y
Kobatake
T
T
Tarui
S
S
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives*; D000273:Adipose Tissue / Q000473:pathology*; D000818:Animals; D003511:Cyclohexanols / Q000627:therapeutic use; D004038:Diet, Reducing; D004187:Disaccharides / Q000627:therapeutic use; D005081:Exercise Therapy; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D009765:Obesity / Q000378:metabolism / Q000628:therapy*; D012867:Skin; D013393:Sucrase / Q000037:antagonists & inhibitors; D014781:Viscera
D003511:Cyclohexanols; D004187:Disaccharides; D065089:Glycoside Hydrolase Inhibitors; C054577:AO 128; D017485:1-Deoxynojirimycin; C059893:4-O-glucopyranosylmoranoline; D013393:Sucrase